MARKET

AZN

AZN

AstraZeneca
NASDAQ

Real-time Quotes | Nasdaq Last Sale

57.07
-0.40
-0.69%
Opening 15:30 07/28 EDT
OPEN
57.04
PREV CLOSE
57.46
HIGH
57.42
LOW
56.87
VOLUME
8.05M
TURNOVER
--
52 WEEK HIGH
60.93
52 WEEK LOW
46.48
MARKET CAP
176.80B
P/E (TTM)
37.75
1D
5D
1M
3M
1Y
5Y
England allows fully vaccinated travelers from U.S. and EU to avoid COVID-19 quarantine
Leon Neal/Getty Images News From August 02, fully vaccinated travelers from the U.S. and EU will no longer be required to undergo quarantine when they arrive in England, Britain’s transport
Seekingalpha · 2h ago
No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study Shows
A person's risk of blood clots does not increase after the second Oxford/AstraZeneca plc (NASDAQ: AZN) COVID-19 vaccine shot.
Benzinga · 3h ago
Notable earnings before Thursday's open
[[AB]],[[ACI]],[[ADS]],[[AER]],[[AGCO]],[[AGIO]],[[ALGM]],[[AMT]],[[AOS]],[[ARES]],[[AZN]],[[BAX]],[[BC]],[[BPMC]],[[BTU]],[[BUD]],[[CARR]],[[CBRE]],[[CBZ]],[[CFR]],[[CFX]],[[CMCO]],[[CMCSA]],[[CMS]],[[CNX]],[[COHU]],[[COLB]],[[COOP]],[[COR]],[[CRS]],[[CTX...
Seekingalpha · 5h ago
Raab calls for global vaccine drive as UK starts donating shots
British Foreign Secretary Dominic Raab warned that the world would not be adequately vaccinated until 2024 unless other countries joined Britain in donating shots to poorer nations, an effort that could bring that date forward to the middle of next year.
Reuters · 6h ago
Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) Signs Its Biggest Deal Yet of $8.3 billion with Verizon Communications Inc. (NYSE: VZ)
WallStreetPR · 7h ago
Dyadic Int'l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development
WallStreetPR · 7h ago
UK starts donating 9 million COVID-19 vaccines overseas
Britain will start delivering 9 million doses of Oxford-AstraZeneca COVID-19 vaccine this week to countries including Indonesia, Jamaica and Kenya to help tackle the pandemic, the government said on Wednesday.
Reuters · 8h ago
Hutchmed Stock Gains On Kick Starting Mid-Stage Gastric Cancer Trial With AstraZeneca's Orpathys
Benzinga · 8h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AZN. Analyze the recent business situations of AstraZeneca through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AZN stock price target is 65.73 with a high estimate of 69.40 and a low estimate of 61.00.
EPS
Institutional Holdings
Institutions: 1.31K
Institutional Holdings: 825.43M
% Owned: 26.64%
Shares Outstanding: 3.10B
TypeInstitutionsShares
Increased
388
128.97M
New
101
16.25M
Decreased
433
124.73M
Sold Out
152
9.83M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.45%
Pharmaceuticals & Medical Research
+2.10%
Key Executives
Non-Executive Chairman/Independent Director
Leif Johansson
Chief Executive Officer/Executive Director
Pascal Soriot
Chief Financial Officer/Executive Director
Marc Dunoyer
Chief Human Resource Officer/General Counsel
Jeffrey Pott
Executive Vice President/Chief Compliance Officer
Katarina Ageborg
Executive Vice President
Jose Baselga
Executive Vice President
Pam Cheng
Executive Vice President
Ruud Dobber
Executive Vice President
David Fredrickson
Executive Vice President
Menelas Pangalos
Executive Vice President
Iskra Reic
Executive Vice President
Leon Wang
Secretary
Adrian Kemp
Non-Executive Director
Euan Ashley
Non-Executive Director
Diana Layfield
Non-Executive Director
Tony Mok
Non-Executive Director
Marcus Wallenberg
Non-Executive Independent Director
Philip Broadley
Non-Executive Independent Director
Michel Demare
Non-Executive Independent Director
Deborah Eldracher
Non-Executive Independent Director
Sherilyn McCoy
Non-Executive Independent Director
Nazneen Rahman
Declaration Date
Dividend Per Share
Ex-Div Date
02/21/2021
Dividend USD 0.93
02/25/2021
07/30/2020
Dividend USD 0.44
08/13/2020
--
Dividend USD 0.93
02/27/2020
--
Dividend USD 0.44
08/08/2019
--
Dividend USD 0.93
02/28/2019
07/26/2018
Dividend USD 0.44
08/09/2018
02/02/2018
Dividend USD 0.93
02/15/2018
07/28/2017
Dividend USD 0.44
08/09/2017
03/14/2017
Dividend USD 0.93
02/15/2017
09/08/2016
Dividend USD 0.44
08/10/2016
02/25/2016
Dividend USD 0.93
02/17/2016
07/30/2015
Dividend USD 0.44
08/12/2015
02/24/2015
Dividend USD 0.94
02/18/2015
07/31/2014
Dividend USD 0.9
08/13/2014
02/07/2014
Dividend USD 1.9
02/19/2014
08/01/2013
Dividend USD 0.9
08/14/2013
  • All
  • Financials
  • Insiders
More
About AZN
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.

Webull offers kinds of AstraZeneca plc (ADR) stock information, including NASDAQ:AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.